Pan Yin

Title: Pan Yin and Targeted Immunotherapy Research

Introduction

Pan Yin is an inventor based in Shanghai, China. His patent work focuses on using mesenchymal stem cells to deliver immune-stimulating signals to tumor sites.

Latest Patents

The provided information lists one patent for Pan Yin: “Immunotherapy Method of Targeted Chemokine and Cytokine Delivery by Mesenchymal Stem Cell.” The method uses a mesenchymal stem cell that expresses one or more immunostimulatory factors, including CCL3, CCL19, CCL21, XCL1, CXCL9, OX40L, 4-1BBL, GITRL, and CD40L. At a tumor site, the cell is designed to attract and activate immune cells that can attack tumor tissue. The patent describes a synergistic immunotherapeutic effect, with particular attention to colorectal cancer cells and the potential for improved tumor-killing activity and fewer side effects. Yin is associated with 1 patent in the information provided.

Career Highlights

Yin is associated with Changen Therapeutics (Shanghai) Co., Ltd. His listed patent reflects work in cellular immunotherapy and targeted delivery of chemokines and cytokines.

Collaborations

The provided information names Wei Qiang Gao and Bin Ma as some of Yin’s coworkers. Their specific roles in the patent or related research are not stated.

Conclusion

Pan Yin’s listed invention explores how engineered mesenchymal stem cells may help direct immune activity toward tumors, including colorectal cancer, and represents his documented contribution to immunotherapy innovation.